Immunohistochemistry and other ancillary techniques in the diagnosis of gestational trophoblastic diseases

Seminars in Diagnostic Pathology

Volumn 31, Issue 3, 2014, Pages 223-232

  Buza, Natalia ^a   Hui, Pei ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ancillary techniques; Gestational trophoblastic disease

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1C;

ARTICLE; CHORIOCARCINOMA; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DNA DETERMINATION; DNA SEQUENCE; GENETIC VARIABILITY; GENOME ANALYSIS; HISTOPATHOLOGY; HUMAN; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; PLOIDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT TANDEM REPEAT; TROPHOBLASTIC TUMOR;

ANCILLARY TECHNIQUES; GESTATIONAL TROPHOBLASTIC DISEASE;

FEMALE; GESTATIONAL TROPHOBLASTIC DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC;

EID: 84902548720     PISSN: 07402570     EISSN: 19301111     Source Type: Journal    
DOI: 10.1053/j.semdp.2014.03.004     Document Type: Article

References (73)

1. Hancock B.W., Newlands E.S., Berkowitz R.S. Gestational Trophoblastic Disease 1997, Chapman & Hall Medical, London; New York. 1st ed.
2. Curry S.L., Hammond C.B., Tyrey L., et al. Hydatidiform mole: diagnosis, management, and long-term followup of 347 patients. Obstet Gynecol 1975, 45:1-8.
3. Kohorn E.I. Hydatidiform mole and gestational trophoblastic disease in Southern Connecticut. Obstet Gynecol 1982, 59:78-84.
4. Lurain J.R., Brewer J.I., Torok E.E., et al. Natural history of hydatidiform mole after primary evacuation. Am J Obstet Gynecol 1983, 145:591-595.
5. Rice L.W., Berkowitz R.S., Lage J.M., et al. Persistent gestational trophoblastic tumor after partial hydatidiform mole. Gynecol Oncol 1990, 36:358-362.
6. Gaber L.W., Redline R.W., Mostoufi-Zadeh M., et al. Invasive partial mole. Am J Clin Pathol 1986, 85:722-724.
7. Kajii T., Ohama K. Androgenetic origin of hydatidiform mole. Nature 1977, 268:633-634.
8. Szulman A.E. Syndromes of hydatidiform moles. Partial vs. complete. J Reprod Med 1984, 29:788-791.
9. Bifulco C., Johnson C., Hao L., et al. Genotypic analysis of hydatidiform mole: an accurate and practical method of diagnosis. Am J Surg Pathol 2008, 32:445-451.
10. Helwani M.N., Seoud M., Zahed L., et al. A familial case of recurrent hydatidiform molar pregnancies with biparental genomic contribution. Hum Genet 1999, 105:112-115.
11. Fisher R.A., Khatoon R., Paradinas F.J., et al. Repetitive complete hydatidiform mole can be biparental in origin and either male or female. Hum Reprod 2000, 15:594-598.
12. Baasanjav B., Usui H., Kihara M., et al. The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles. Hum Reprod 2010, 25:1183-1191.
13. Wake N., Fujino T., Hoshi S., et al. The propensity to malignancy of dispermic heterozygous moles. Placenta 1987, 8:319-326.
14. Williams D., Hodgetts V., Gupta J. Recurrent hydatidiform moles. Eur J Obstet Gynecol Reprod Biol 2010, 150:3-7.
15. Lawler S.D., Fisher R.A., Pickthall V.J., et al. Genetic studies on hydatidiform moles. I. The origin of partial moles. Cancer Genet Cytogenet 1982, 5:309-320.
16. Jacobs P.A., Szulman A.E., Funkhouser J., et al. Human triploidy: relationship between parental origin of the additional haploid complement and development of partial hydatidiform mole. Ann Hum Genet 1982, 46:223-231.
17. Surti U., Szulman A.E., Wagner K., et al. Tetraploid partial hydatidiform moles: two cases with a triple paternal contribution and a 92, XXXY karyotype. Hum Genet 1986, 72:15-21.
18. Sheppard D.M., Fisher R.A., Lawler S.D., et al. Tetraploid conceptus with three paternal contributions. Hum Genet 1982, 62:371-374.
19. Zaragoza M.V., Surti U., Redline R.W., et al. Parental origin and phenotype of triploidy in spontaneous abortions: predominance of diandry and association with the partial hydatidiform mole. Am J Hum Genet 2000, 66:1807-1820.
20. Genest D.R. Partial hydatidiform mole: clinicopathological features, differential diagnosis, ploidy and molecular studies, and gold standards for diagnosis. Int J Gynecol Pathol 2001, 20:315-322.
21. Szulman A.E., Surti U. The syndromes of hydatidiform mole. I. Cytogenetic and morphologic correlations. Am J Obstet Gynecol 1978, 131:665-671.
22. Szulman A.E., Surti U. The syndromes of hydatidiform mole. II. Morphologic evolution of the complete and partial mole. Am J Obstet Gynecol 1978, 132:20-27.
23. Paradinas F.J., Browne P., Fisher R.A., et al. A clinical, histopathological and flow cytometric study of 149 complete moles, 146 partial moles and 107 non-molar hydropic abortions. Histopathology 1996, 28:101-110.
24. Fukunaga M. Histopathologic study of partial hydatidiform moles and DNA triploid placentas. Pathol Int 1994, 44:528-534.
25. Buza N., Hui P. Partial hydatidiform mole: histologic parameters in correlation with DNA genotyping. Int J Gynecol Pathol 2013, 32:307-315.
26. Lipata F., Parkash V., Talmor M., et al. Precise DNA genotyping diagnosis of hydatidiform mole. Obstet Gynecol 2010, 115:784-794.
27. van Lijnschoten G., Arends J.W., Geraedts J.P. Comparison of histological features in early spontaneous and induced trisomic abortions. Placenta 1994, 15:765-773.
28. van Lijnschoten G., Arends J.W., Leffers P., et al. The value of histomorphological features of chorionic villi in early spontaneous abortion for the prediction of karyotype. Histopathology 1993, 22:557-563.
29. Redline R.W., Hassold T., Zaragoza M. Determinants of villous trophoblastic hyperplasia in spontaneous abortions. Mod Pathol 1998, 11:762-768.
30. Paradinas F.J., Fisher R.A., Browne P., et al. Diploid hydatidiform moles with fetal red blood cells in molar villi. 1-Pathology, incidence, and prognosis. J Pathol 1997, 181:183-188.
31. Fisher R.A., Paradinas F.J., Soteriou B.A., et al. Diploid hydatidiform moles with fetal red blood cells in molar villi. 2-Genetics. J Pathol 1997, 181:189-195.
32. Sebire N.J., Fisher R.A., Rees H.C. Histopathological diagnosis of partial and complete hydatidiform mole in the first trimester of pregnancy. Pediatr Dev Pathol 2003, 6:69-77.
33. Fukunaga M., Katabuchi H., Nagasaka T., et al. Interobserver and intraobserver variability in the diagnosis of hydatidiform mole. Am J Surg Pathol 2005, 29:942-947.
34. Gupta M., Vang R., Yemelyanova A.V., et al. Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis for both recently trained and experienced gynecologic pathologists. Am J Surg Pathol 2012, 36:1747-1760.
35. Lage J.M., Mark S.D., Roberts D.J., et al. A flow cytometric study of 137 fresh hydropic placentas: correlation between types of hydatidiform moles and nuclear DNA ploidy. Obstet Gynecol 1992, 79:403-410.
36. McFadden D.E., Robinson W.P. Phenotype of triploid embryos. J Med Genet 2006, 43:609-612.
37. Esteban J.M., Sheibani K., Owens M., et al. Effects of various fixatives and fixation conditions on DNA ploidy analysis. A need for strict internal DNA standards. Am J Clin Pathol 1991, 95:460-466.
38. Frierson H.F. Flow cytometric analysis of ploidy in solid neoplasms: comparison of fresh tissues with formalin-fixed paraffin-embedded specimens. Hum Pathol 1988, 19:290-294.
39. Chiang S., Fazlollahi L., Nguyen A., et al. Diagnosis of hydatidiform moles by polymorphic deletion probe fluorescence in situ hybridization. J Mol Diagn 2011, 13:406-415.
40. Chilosi M., Piazzola E., Lestani M., et al. Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease. Lab Invest 1998, 78:269-276.
41. Fukunaga M. Immunohistochemical characterization of p57(KIP2) expression in early hydatidiform moles. Hum Pathol 2002, 33:1188-1192.
42. Castrillon D.H., Sun D., Weremowicz S., et al. Discrimination of complete hydatidiform mole from its mimics by immunohistochemistry of the paternally imprinted gene product p57KIP2. Am J Surg Pathol 2001, 25:1225-1230.
43. Ronnett B.M., DeScipio C., Murphy K.M. Hydatidiform moles: ancillary techniques to refine diagnosis. Int J Gynecol Pathol 2011, 30:101-116.
44. Lewis G.H., DeScipio C., Murphy K.M., et al. Characterization of androgenetic/biparental mosaic/chimeric conceptions, including those with a molar component: morphology, p57 immnohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease. Int J Gynecol Pathol 2013, 32:199-214.
45. McConnell T.G., Norris-Kirby A., Hagenkord J.M., et al. Complete hydatidiform mole with retained maternal chromosomes 6 and 11. Am J Surg Pathol 2009, 33:1409-1415.
46. Fisher R.A., Nucci M.R., Thaker H.M., et al. Complete hydatidiform mole retaining a chromosome 11 of maternal origin: molecular genetic analysis of a case. Mod Pathol 2004, 17:1155-1160.
47. DeScipio C., Haley L., Beierl K., et al. Diandric triploid hydatidiform mole with loss of maternal chromosome 11. Am J Surg Pathol 2011, 35:1586-1591.
48. Cheung A.N., Ngan H.Y., Chen W.Z., et al. The significance of proliferating cell nuclear antigen in human trophoblastic disease: an immunohistochemical study. Histopathology 1993, 22:565-568.
49. Suresh U.R., Hale R.J., Fox H., et al. Use of proliferation cell nuclear antigen immunoreactivity for distinguishing hydropic abortions from partial hydatidiform moles. J Clin Pathol 1993, 46:48-50.
50. Olvera M., Harris S., Amezcua C.A., et al. Immunohistochemical expression of cell cycle proteins E2F-1, Cdk-2, Cyclin E, p27(kip1), and Ki-67 in normal placenta and gestational trophoblastic disease. Mod Pathol 2001, 14:1036-1042.
51. Zhivotovsky L.A., Bennett L., Bowcock A.M., et al. Human population expansion and microsatellite variation. Mol Biol Evol 2000, 17:757-767.
52. Hui P. Molecular diagnosis of gestational trophoblastic disease. Expert Rev Mol Diagn 2010, 10:1023-1034.
53. McConnell T.G., Murphy K.M., Hafez M., et al. Diagnosis and subclassification of hydatidiform moles using p57 immunohistochemistry and molecular genotyping: validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach. Am J Surg Pathol 2009, 33:805-817.
54. Murphy K.M., McConnell T.G., Hafez M.J., et al. Molecular genotyping of hydatidiform moles: analytic validation of a multiplex short tandem repeat assay. J Mol Diagn 2009, 11:598-605.
55. Buza N, Hui P. Egg donor pregnancy: a potential pitfall in DNA genotyping diagnosis of hydatidiform moles. Int J Gynecol Pathol, in press.
56. Baergen R.N., Kelly T., McGinniss M.J., et al. Complete hydatidiform mole with a coexistent embryo. Hum Pathol 1996, 27:731-734.
57. Wax J.R., Pinette M.G., Chard R., et al. Prenatal diagnosis by DNA polymorphism analysis of complete mole with coexisting twin. Am J Obstet Gynecol 2003, 188:1105-1106.
58. Makrydimas G., Sebire N.J., Thornton S.E., et al. Complete hydatidiform mole and normal live birth: a novel case of confined placental mosaicism: case report. Hum Reprod 2002, 17:2459-2463.
59. Banet N., Descipio C., Murphy K.M., et al. Characteristics of hydatidiform moles: analysis of a prospective series with p57 immunohistochemistry and molecular genotyping. Mod Pathol 2014, 27:238-254.
60. Buza N., Hui P. Gestational trophoblastic disease: histopathological diagnosis in the molecular era. Diagn Histopathol 2010, 16:526-537.
61. Mao T.L., Kurman R.J., Huang C.C., et al. Immunohistochemistry of choriocarcinoma: an aid in differential diagnosis and in elucidating pathogenesis. Am J Surg Pathol 2007, 31:1726-1732.
62. Kalhor N., Ramirez P.T., Deavers M.T., et al. Immunohistochemical studies of trophoblastic tumors. Am J Surg Pathol 2009, 33:633-638.
63. Lurain J.R. Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia. Am J Obstet Gynecol 2011, 204:11-18.
64. Buza N., Rutherford T., Hui P. Genotyping diagnosis of nongestational choriocarcinoma involving fallopian tube and broad ligament: a case study. Int J Gynecol Pathol 2014, 33:58-63.
65. Zhao J., Xiang Y., Wan X.R., et al. Molecular genetic analyses of choriocarcinoma. Placenta 2009, 30:816-820.
66. Koo H.L., Choi J., Kim K.R., et al. Pure non-gestational choriocarcinoma of the ovary diagnosed by DNA polymorphism analysis. Pathol Int 2006, 56:613-616.
67. Shih I.M., Kurman R.J. Epithelioid trophoblastic tumor: a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma. Am J Surg Pathol 1998, 22:1393-1403.
68. Fadare O., Parkash V., Carcangiu M.L., et al. Epithelioid trophoblastic tumor: clinicopathological features with an emphasis on uterine cervical involvement. Mod Pathol 2006, 19:75-82.
69. Shih I.M., Kurman R.J. The pathology of intermediate trophoblastic tumors and tumor-like lesions. Int J Gynecol Pathol 2001, 20:31-47.
70. Shih I.M., Kurman R.J. p63 Expression is useful in the distinction of epithelioid trophoblastic and placental site trophoblastic tumors by profiling trophoblastic subpopulations. Am J Surg Pathol 2004, 28:1177-1183.
71. Xu M.L., Yang B., Carcangiu M.L., et al. Epithelioid trophoblastic tumor: comparative genomic hybridization and diagnostic DNA genotyping. Mod Pathol 2009, 22:232-238.
72. Baergen R.N., Rutgers J.L., Young R.H., et al. Placental site trophoblastic tumor: a study of 55 cases and review of the literature emphasizing factors of prognostic significance. Gynecol Oncol 2006, 100:511-520.
73. Ichikawa N., Zhai Y.L., Shiozawa T., et al. Immunohistochemical analysis of cell cycle regulatory gene products in normal trophoblast and placental site trophoblastic tumor. Int J Gynecol Pathol 1998, 17:235-240.